2型炎症严重喘的生物疗法:目前的证据,患者选择和未来的前景
1Department of Intellectual property Rights, Research and Development cell, Lovely Professional University, Jalandhar - Delhi Grand Trunk Rd, Phagwara, Punjab 144411, India.
概括
生物疗法提供了一种革命性的方法来治疗严重过敏性喘,通过准特定的免疫路径. 使用生物标志物的个性化治疗改善了结果,但这些先进药物的可访问性和成本仍然是这些先进药物的挑战.
科学领域:
- 免疫学和肺病学.
- 药理学和治疗创新
背景情况:
- 过敏性喘管理已经被生物疗法所改变.
- 这些疗法针对特定的免疫调节,以改善患者的治疗结果.
研究的目的:
- 综合当前关于严重过敏性喘生物治疗的临床证据.
- 探索患者选择标准,安全性和未来的方向.
主要方法:
- 在PubMed,Embase和Cochrane的系统文献搜索到2025年.
- 优先考虑随机对照试验,元分析和针对IgE和2型炎症的生物制剂的现实研究.
主要成果:
- 生物药物显著减少了喘恶化,住院治疗和皮质类固醇使用.
- 生物标志物,如乙氨基细胞计数,IgE和FeNO,可以优化治疗反应.
- 挑战包括成本,可访问性和长期安全数据.
结论:
- 针对2型炎症的生物制剂是过敏喘护理中的范式转变.
- 个性化医疗方法增强了临床效益,需要进一步的研究来优化.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma III: Clinical Manifestations
49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49


